Login
$AGL
$90.34 +$0.63 (0.7%) Close

$AGL 4/A SEC Filings

Filed On Filing
03 Apr 2025 Form 4/A: Schwaneke Jeffrey A., Chief Financial Officer

Bought 22,300 shares ($250K) · Received 428,922 shares as a grant or award · Granted 673,077 Options (Right to buy)

16 Jun 2023 Form 4/A: Sell Steven, Director

Received 39,530 shares as a grant or award · Gave up 4,216 shares to cover exercise price or tax ($120K) · Granted 68,348 Options (Right to buy)

09 Jan 2023 Form 4/A: Kornitzer Benjamin, Chief Med. & Quality Officer

Received 5,398 shares by exercise or conversion ($28.2K)

21 Oct 2022 Form 4/A: Shaker Benjamin, Chief Markets Officer

Sold 20,452 shares ($406K) · Sold 29,548 shares ($602K)

29 Sep 2022 Form 4/A: Venkatachaliah Girish, Chief Technology Officer

Gave up 476 shares to cover exercise price or tax ($11K)

29 Sep 2022 Form 4/A: Sobotka Glenn, Chief Accounting Officer

Gave up 334 shares to cover exercise price or tax ($7.71K)

29 Sep 2022 Form 4/A: Shaker Benjamin, Chief Markets Officer

Gave up 1,507 shares to cover exercise price or tax ($34.8K)

29 Sep 2022 Form 4/A: Kornitzer Benjamin, Chief Med. & Quality Officer

Gave up 427 shares to cover exercise price or tax ($9.85K)

29 Sep 2022 Form 4/A: Desai Veeral, Chief Strategy & Dev. Officer

Gave up 1,482 shares to cover exercise price or tax ($34.2K)

29 Sep 2022 Form 4/A: Bensley Timothy, Chief Financial Officer

Gave up 1,430 shares to cover exercise price or tax ($33K)

29 Apr 2022 Form 4/A: Kornitzer Benjamin, Chief Med. & Quality Officer

Exercised 6,477 Options (Rights to Buy) · Exercised 6,296 Options (Rights to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support